Navigation Links
VCU Massey Cancer Center spearheads novel clinical study for lymphoma patients
Date:9/2/2008

The Virginia Commonwealth University Massey Cancer Center recently opened a National Cancer Institute (NCI)-sponsored, phase II clinical study for certain sub-types of non-Hodgkin's lymphoma.

The study is based on research from VCU Massey Cancer Center as well as other centers suggesting that combining two novel, recently approved drugs that have shown effectiveness in certain blood cancers may be active in patients with diffuse large B-cell lymphoma, or mantle cell lymphoma. The study is intended for patients whose disease has progressed following treatment with other regimens.

Other NCI centers participating in this novel lymphoma study through the NCI's Southeast Phase II Consortium include H. Lee Moffitt Cancer Center and Research Institute (Tampa, Fla.), which is the coordinating center; the University of North Carolina Lineberger Comprehensive Cancer Center (Chapel Hill, N.C.); and the Vanderbilt-Ingram Cancer Center (Nashville, Tenn.). Also planning to participate are Montefiore-Einstein Cancer Center (New York); and New York Presbyterian Hospital / Weill Cornell Medical College, both of which are in the NCI-sponsored New York Phase II Consortium.

The investigators hope to learn whether these types of lymphoma respond to treatment with the combination of bortezomib, marketed as Velcade, and vorinostat, marketed as Zolinza. They also intend to learn about the side effects of this drug regimen and whether certain features of these lymphomas might predict for response to this regimen.

Steven Grant, M.D., principal investigator of the study and associate director for translational research at VCU Massey Cancer Center, is among a number of researchers worldwide who have reported synergistic interactions between proteasome inhibitors such as bortezomib and histone deacetylase inhibitors such as vorinostat in leukemia and other hematologic malignancies. Other cancer centers are currently exploring this drug combination in
'/>"/>

Contact: Andrea Butler
albutler@vcu.edu
804-628-2111
Virginia Commonwealth University
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. VCU Massey Cancer Center to partner with Israeli biotech firm
2. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
3. Survival differences by race most apparent in advanced stages of breast cancer
4. MRI finds breast cancer before it becomes dangerous
5. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
6. Pathway links inflammation, angiogenesis and breast cancer
7. Radiologists encouraged to look beyond cancer for clinically unseen diseases
8. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
9. Immune deficiency linked to a type of eye cancer
10. Drop in breast cancer incidence linked to hormone use, not mammograms
11. Breast cancer prevention practices vary across Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... A medical malpractice case which was filed ... by Lori Mandel, an office manager in her 50’s, ... Ms. Mandel sought the medical expertise of an ... that affected the quality of her life and her ... that her doctor rendered conservative treatment for 2 years, ...
(Date:5/23/2013)... can cause rapidly progressing, life threatening meningitis and meningococcal ... have not known how it attaches to the human ... attaches to the airway to colonise", People can be ... while some people progress to invasive disease. To ... how the bacterium colonises the airway. Now that the ...
(Date:5/23/2013)... , , WEDNESDAY, May 22 (HealthDay News) -- The success of ... born with a serious airway malformation sheds light on new ... A report in the May 23 New England Journal ... At first, the baby born five weeks early seemed ... eating when he was 6 weeks old. Just two weeks ...
(Date:5/23/2013)... DRE, Inc. is now offering the DRE ... upgrade older model DRE or BFW halogen headlights to ... , DRE and BFW customers can easily and affordably ... to LED with DRE’s American-made Xavier-C3 LED headlight conversion ... a bright, clean and even field of illumination with ...
(Date:5/23/2013)... May 23, 2013 In Florida, residents have ... This doesn’t mean, however, that Florida’s good luck will continue, ... . This year, he encourages residents, it is important to ... 2013, forecasters are predicting there to be a 50-percent chance ... . With hurricane season lasting from June 1 to November ...
Breaking Medicine News(10 mins):Health News:New York Law Journal Releases Top Medical Malpractice Case for 2012: NY Supreme Court Awards $8.6 Million to Plaintiff after Doctor's Misdiagnosis Led to Personal Injury 2Health News:New York Law Journal Releases Top Medical Malpractice Case for 2012: NY Supreme Court Awards $8.6 Million to Plaintiff after Doctor's Misdiagnosis Led to Personal Injury 3Health News:New discovery in fight against deadly meningococcal disease 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 3Health News:New DRE, Inc. LED Conversion Kit Allows Doctors to Upgrade Older Halogen Technology Without Replacing Entire Lighting Systems 2Health News:New DRE, Inc. LED Conversion Kit Allows Doctors to Upgrade Older Halogen Technology Without Replacing Entire Lighting Systems 3Health News:As Hurricane Season Nears, Skylake Insurance Encourages Florida Residents To Prepare Early For Safety 2
... There,s little benefit to parents or baby in learning before ... new study suggests. Researchers led by Dr. James Robbins, ... 235 mothers of children aged 2 to 7 years with ... condition was identified before birth (prenatally) in 46 percent of ...
... , FRIDAY, Nov. 26 (HealthDay News) -- Most American ... the topic is far less likely to arise in homes without ... half of American households have a gun, and nearly 30 children ... owned by the child,s family or friends, according to researchers at ...
... HealthDay Reporter , WEDNESDAY, Nov. 24 (HealthDay News) ... and want to keep the weight off, a new Danish ... refined carbohydrates. Based on the findings, the researchers advise ... whole-grain breads. The glycemic index (GI) is a measure of ...
... devastating cholera outbreaks in refugee camps in earthquake-wracked Haiti, ... George Washington University, and the International Vaccine Institute (IVI) ... stockpile of cholera vaccines for future humanitarian use. ... maintaining a stockpile of several million doses of cholera ...
... Amanda Gardner HealthDay Reporter , WEDNESDAY, Nov. 24 ... blood cancers with bone marrow and blood stem cell transplants ... and death, a new study shows. Between the early ... the overall risk of death in an analysis of more ...
... year has brought to light both the promise and ... the most deadly form of skin cancer. Early clinical ... cancer-causing gene revealed impressive results in patients whose cancers ... short-lived, as the tumors invariably returned a few months ...
Cached Medicine News:Health News: Gun-Safety Talk a Safe Bet for All Families, Experts Say 2Health News:More Protein, Fewer Refined Carbs May Keep Weight Off 2Health News:More Protein, Fewer Refined Carbs May Keep Weight Off 3Health News:Experts urge US to create emergency cholera vaccine stockpile for humanitarian use 2Health News:Experts urge US to create emergency cholera vaccine stockpile for humanitarian use 3Health News:Experts urge US to create emergency cholera vaccine stockpile for humanitarian use 4Health News:Study Finds Big Strides Made in Treating Leukemia, Lymphoma in Past Decade 2Health News:Study Finds Big Strides Made in Treating Leukemia, Lymphoma in Past Decade 3Health News:Study Finds Big Strides Made in Treating Leukemia, Lymphoma in Past Decade 4Health News:Researchers shine light on how some melanoma tumors evade drug treatment 2Health News:Researchers shine light on how some melanoma tumors evade drug treatment 3
(Date:5/23/2013)... 2013 Halozyme Therapeutics, Inc. (NASDAQ: ... David A. Ramsay as ... Vice President, Corporate Development at Halozyme. ... his established financial management experience and his recent ... our commercial group for the last four years, ...
(Date:5/23/2013)... SAN DIEGO , May 23, 2013  MedVantx, ... to consumer pharmaceutical distribution channel announced today the Company ... platform to manage $1.5B in pharmaceutical products and the ... quality akin to cGMP facilities in its specialty home ... . The Company provides leading pharmaceutical manufacturers, physicians, health ...
(Date:5/23/2013)... , May 23, 2013   BioLife Solutions ... of proprietary clinical grade hypothermic storage and ... and contract aseptic media manufacturer , today announced ... & Regenerative Medicine Congress 2013 this week in ... http://photos.prnewswire.com/prnh/20090814/BIOLIFELOGO ) Dr. Aby J. Mathew, BioLife,s ...
Breaking Medicine Technology:Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 2BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 3
... , RALEIGH, N.C., Dec. 9 ... Head of Infectious Diseases Carl Kraus, M.D., Vice President ... with John Powers, M.D., Assistant Professor of Medicine ... considerations in anti-infective drug development. , Understanding the current ...
... SAN DIEGO, Dec. 9 Sangart, Inc., a global ... to enhance the perfusion and oxygenation of ischemic (oxygen ... initiation of a dose-finding study designed to evaluate the ... care in severely injured trauma patients with lactic acidosis ...
Cached Medicine Technology:PRA International Hosts an Infectious Diseases Audio Conference 2PRA International Hosts an Infectious Diseases Audio Conference 3Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3
Used to introduce balloon, closed and non-tapered end catheters or other devices for intervention....
Used to introduce balloon, electrode, closed or non-tapered end catheters and other devices for intervention....
Used to introduce large balloon, closed and non-tapered end catheters or other devices for intervention....
Used to introduce large devices for vascular intervention....
Medicine Products: